These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 4279526)

  • 21. [Antiplasmin and its effect on the process of fibrinolysis in experiments].
    Kudriashov BA; Pastorova VE
    Biull Eksp Biol Med; 1966 Feb; 61(2):40-2. PubMed ID: 4235805
    [No Abstract]   [Full Text] [Related]  

  • 22. Recent progress in fibrinolysis.
    Mannucci PM; Minetti D; Mari D
    Southeast Asian J Trop Med Public Health; 1979 Sep; 10(3):328-35. PubMed ID: 160079
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of nafamostat mesilate on coagulation and fibrinolysis in hepatic resection.
    Shimada M; Matsumata T; Shirabe K; Kamakura T; Taketomi A; Sugimachi K
    J Am Coll Surg; 1994 May; 178(5):498-502. PubMed ID: 8167888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pathophysiological role of fibrinolysis inhibitors.
    Lijnen HR; Collen D
    Ric Clin Lab; 1984; 14(3):499-505. PubMed ID: 6084295
    [No Abstract]   [Full Text] [Related]  

  • 25. [Endogenous and exogenous fibrinolysis].
    Perlick E; Wilfert K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(1):28-32. PubMed ID: 4189368
    [No Abstract]   [Full Text] [Related]  

  • 26. [Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy].
    Veremeenko KN; Kizim AI
    Vopr Med Khim; 1984; 30(5):13-22. PubMed ID: 6084892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antifibrinolytic therapy of gynecologic hemorrhages (literature survey)].
    Skipetrov VP
    Akush Ginekol (Mosk); 1974 Oct; (10):1-6. PubMed ID: 4280255
    [No Abstract]   [Full Text] [Related]  

  • 28. [Antithrombin and antiplasmin effect of 4-amidinophenylpyruvic acid in vivo].
    Markwardt F; Klöcking HP; Nowak G
    Thromb Diath Haemorrh; 1970 Oct; 24(1):240-7. PubMed ID: 5483964
    [No Abstract]   [Full Text] [Related]  

  • 29. Changes in the coagulation and fibrinolytic systems predisposing to thrombosis.
    Nilsson IM
    Acta Chir Scand Suppl; 1968; 387():15-22. PubMed ID: 4240349
    [No Abstract]   [Full Text] [Related]  

  • 30. [Compensatory-adaptive reactions of the blood coagulating and fibrinolytic systems in the main cardiovascular diseases].
    Gritsiuk AI
    Vrach Delo; 1976 Jan; (1):13-20. PubMed ID: 128903
    [No Abstract]   [Full Text] [Related]  

  • 31. [The antifibrinolytic therapy of gynecologic hemorrhages].
    Koutský J; Padovec J; Jirásek JE; Rybák M; Hladovec J; Mansfeld V
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):151-65. PubMed ID: 4174653
    [No Abstract]   [Full Text] [Related]  

  • 32. Coagulation and fibrinolytic studies following use of proteinase inhibitors in prostatic surgery.
    Phillips LL; Weiss R; Wolf C
    Ann N Y Acad Sci; 1968 Jun; 146(2):737-44. PubMed ID: 4239442
    [No Abstract]   [Full Text] [Related]  

  • 33. Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner. Study of seven plasminogen activators in an internal clot lysis model.
    Guimarães AH; Rijken DC
    Thromb Haemost; 2004 Mar; 91(3):473-9. PubMed ID: 14983222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Protease inhibitors and antifibrinolytic therapy].
    Manrique R
    Arq Bras Cardiol; 1984 Nov; 43(5):355-60. PubMed ID: 6242229
    [No Abstract]   [Full Text] [Related]  

  • 35. Experimental and clinical studies on the thrombin-like enzyme from the venom of Bothrops atrox. On the primary structure of fragment E.
    Egberg N
    Acta Physiol Scand Suppl; 1973; 400():1-47. PubMed ID: 4599946
    [No Abstract]   [Full Text] [Related]  

  • 36. Fibrin deposition in the ribbit kidney produced by protease inhibitors.
    Beller FK; Mitchell PS; Gorstein F
    Thromb Diath Haemorrh; 1967 May; 17(3-4):427-39. PubMed ID: 5301528
    [No Abstract]   [Full Text] [Related]  

  • 37. Antifibrinolytic properties of basic proteins.
    Worowski K; Farbiszewski R; Rzeczycki W
    Experientia; 1972 Apr; 28(4):398-9. PubMed ID: 4260909
    [No Abstract]   [Full Text] [Related]  

  • 38. [Thromboembolic complications, the coagulation and fibrinolytic blood system in heart defects with pronounced circulatory insufficiency].
    Gritsiuk AI
    Kardiologiia; 1969 Sep; 9(9):21-8. PubMed ID: 4244024
    [No Abstract]   [Full Text] [Related]  

  • 39. [Complex compounds of plasminogen with heparin (PGH) and plasmin with heparin (PH) and their importance in regulating the liquid state of the blood].
    Kudriashov BA; Liapina LA
    Probl Gematol Pereliv Krovi; 1972 Apr; 17(4):28-30. PubMed ID: 4282511
    [No Abstract]   [Full Text] [Related]  

  • 40. [Possibilities of the method of fibrin plates for determination of the activity of the blood fibrinolytic system components].
    Butorov VN; Bokarev IN
    Lab Delo; 1978; (5):271-3. PubMed ID: 79009
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.